
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back? - 2
Investigating the Medical advantages of Aloe Vera - 3
Support Your Investment funds with These Individual accounting Thoughts - 4
Vote In favor of Your Favored Sort Of Bevarage - 5
NASA releases stunning first images of Earth taken by the Artemis II astronauts
Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
Japan deploys the military to counter a surge in bear attacks
Hundreds show fascist salute at rally in Rome in annual ritual
Merz: 80% of Syrians in Germany should return in three years
Everything you should know before booking a trip to Spain
Far-right leader Le Pen to attend Brigitte Bardot's funeral
The pace of hiring just fell to the lowest since 2011, outside of the pandemic
As nations push for more ambition at climate talks, chairman says they may get it













